Omeros Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
4,299
Transactions
10,296
2021 Total
$1.6M
Payment Breakdown by Category
Research$2.8M (53.8%)
Consulting$1.4M (26.7%)
Food & Beverage$256,920 (4.9%)
Travel$105,922 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 249 | 53.8% |
| Consulting Fee | $1.4M | 455 | 26.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,914 | 141 | 6.8% |
| Food and Beverage | $256,920 | 8,990 | 4.9% |
| Honoraria | $238,732 | 81 | 4.5% |
| Travel and Lodging | $105,922 | 360 | 2.0% |
| Education | $66,607 | 19 | 1.3% |
| Grant | $3,000 | 1 | 0.1% |
Payments by Type
Research
$2.8M
240 transactions
General
$2.4M
10,047 transactions
Ownership
$0
9 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OMS721-GNP-001 | $1.2M | 15 | 150 |
| An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients | $636,578 | 0 | 24 |
| OMS 721-TMA-001 | $295,119 | 0 | 10 |
| A Retrospective Study to Determine the Incidence of, Risk Factors for, and Outcomes of Patients with Transplant-Associated Thrombotic Microangiopathy (TA-TMA) After Allogeneic Hematopoietic Cell Transplantation | $268,900 | 0 | 11 |
| OMS302-ILR-007 | $101,490 | 0 | 21 |
| Pain Control and Reduction in Opioid Use | $50,000 | 0 | 2 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 | $31,549 | 0 | 2 |
| OMS721-TMA-001 | $16,076 | 0 | 15 |
| OMS824-HTD-002 | $2,122 | 0 | 1 |
| OMS182399 | $700.00 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Dr. Lynn Frumkin, M.d, M.D | Infectious Disease | Seattle, WA | $176,898 | $0 |
| Dr. Eric Donnenfeld, M.d, M.D | Ophthalmology | Garden City, NY | $165,628 | $0 |
| Keith Walter, Md, MD | Ophthalmology | Winston Salem, NC | $139,360 | $0 |
| Dr. Larry Patterson, M.d, M.D | Ophthalmology | Crossville, TN | $98,893 | $0 |
| Dr. Robert Osher, Md, MD | Ophthalmology | Cincinnati, OH | $97,558 | $0 |
| Steven Silverstein, Md, MD | Ophthalmology | Kansas City, MO | $90,477 | $0 |
| Dr. Mark Pyfer, M.d, M.D | Ophthalmology | Jenkintown, PA | $78,574 | $0 |
| Miguel Perales, Md, MD | Medical Oncology | New York, NY | $73,618 | $0 |
| Denise Visco, M.d, M.D | Ophthalmology | York, PA | $69,533 | $0 |
| Dr. Douglas Katsev, Md, MD | Ophthalmology | Santa Barbara, CA | $50,632 | $0 |
| Dr. Laura Kooienga, Md, MD | Nephrology | Denver, CO | $46,714 | $0 |
| Terry Kim, M.d, M.D | Ophthalmology | Durham, NC | $45,768 | $0 |
| Cynthia Matossian, Md, MD | Ophthalmology | Pennington, NJ | $44,390 | $0 |
| David Goodkin, M.d, M.D | Nephrology | Bellevue, WA | $41,850 | $0 |
| Johnny Gayton, M.d, M.D | Ophthalmology | Warner Robins, GA | $40,394 | $0 |
| Peter Demopulos, Md, MD | Cardiovascular Disease | Bellevue, WA | $39,375 | $0 |
| Ambarish Athavale, Md, MD | Internal Medicine | San Diego, CA | $39,232 | $0 |
| Dr. Geoffrey Block, Md, MD | Nephrology | Lone Tree, CO | $38,068 | $0 |
| Sonata Jodele, M.d, M.D | Pediatric Hematology-Oncology | Cincinnati, OH | $37,493 | $0 |
| Dr. Mitchell Jackson, Md, MD | Ophthalmology | Lake Villa, IL | $35,099 | $0 |
| Dr. Rebecca Metzinger, Md, MD | Ophthalmology | New Orleans, LA | $33,932 | $0 |
| Richard Lafayette, M.d, M.D | Internal Medicine | Stanford, CA | $33,478 | $0 |
| Sergio Giralt, M.d, M.D | Hematology & Oncology | New York, NY | $30,835 | $0 |
| Vincent Ho, Md, MD | Medical Oncology | Boston, MA | $26,527 | $0 |
| Diana Kersten, M.d, M.D | Ophthalmology | Laguna Hills, CA | $24,000 | $0 |
Ad
Top Products
- Omidria $1.3M
- OMIDRIA $738,978
Associated Products (4)
- Omidria $1.6M
- OMIDRIA $896,672
- Narsoplimab $391,825
- narsoplimab $84,617
Payment Categories
- Food & Beverage $256,920
- Consulting $1.4M
- Travel & Lodging $105,922
- Research $2.8M
About Omeros Corporation
Omeros Corporation has made $5.3M in payments to 4,299 healthcare providers, recorded across 10,296 transactions in the CMS Open Payments database. In 2021, the company paid $1.6M. The top product by payment volume is Omidria ($1.3M).
Payments were distributed across 87 medical specialties. The top specialty by payment amount is Ophthalmology ($1.5M to 2,549 doctors).
Payment categories include: Food & Beverage ($256,920), Consulting ($1.4M), Research ($2.8M), Travel & Lodging ($105,922).
Omeros Corporation is associated with 4 products in the CMS Open Payments database, including Omidria, OMIDRIA, and Narsoplimab.